FDA Approved: CITALOPRAM HYDROBROMIDE — Original Application (Glenmark Therapeutics Inc., USA)

View source ↗

Summary

FDA approved Glenmark Therapeutics' generic citalopram hydrobromide under Original Application (ANDA 077654). Indication is major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram Hydrobromide (citalopram hydrobromide)

Snippet

ORIG AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)